ENSKYCE | EP | Reference Standards | EDQM | PharmaCompass.com

Please Wait

Applying Filters...

ENSKYCE
EDQM

ENSKYCE

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

28 API Suppliers, 8 USDMF, 6 CEP/COS, 2 JDMF, 6 EU WC, 4 NDC API, 17 Listed Suppliers

DEVELOPMENTS

10 Drugs in Development

10 Drugs in Development

INTERMEDIATES

4 Intermediate Suppliers

4 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

207 FDF Dossiers, 35 FDA Orange Book, 144 Europe, 16 Canada, 4 South Africa, 8 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL-21 - 0.15MG;0.03MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL-28 - 0.1MG,0.125MG,0.15MG;0.025MG,0.025MG,0.025MG

DIGITAL CONTENT

12 News #PharmaBuzz

12 News #PharmaBuzz

GLOBAL SALES INFORMATION

14 US Medicaid Prescriptions, 16 Regulatory FDF Prices, 6 Annual Reports

MARKET PLACE

5 APIs, 1 FDF Dossiers

REF. STANDARDS & IMPURITIES

2 EDQM, 7 Others

Xls

Filters

Filters

FILTER :

filter Order Code Reset all filters

2 All

01 1Y0000509

02 1Y0000510

filter CAS Number Reset all filters

filter Reference Standard Reset all filters

Product Main Page

01

EDQM, Council of Europe

Desogestrel for system suitability

Stanford Drug Discovery Symposium

Not Confirmed

02

EDQM, Council of Europe

Desogestrel

Stanford Drug Discovery Symposium

Not Confirmed

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.